A matched case-control study was undertaken in 10 centers in Germany and the United
Kingdom to explore the association of current use of major combination oral contraceptives …

Previous discussions have indicated that the small increases of risk of venous
thromboembolism (VTE) associated with newer combined oral contraceptives (third …

Background Four studies published since December, 1995, reported that the incidence of
venous thromboembolism (VTE) was higher in women who used oral contraceptives (OCs) …

Objective To assess the risk of venous thromboembolism from use of combined oral
contraceptives according to progestogen type and oestrogen dose. Design National …

This study investigated the risk of venous thromboembolic disease (VTE) between second
and third generation combined oral contraceptives, using the German MediPlus database of …

Background. New studies about the influence of hormonal contraception on the risk of
venous thromboembolism (VTE) have been published. Aim. To evaluate new …

Objective: To test whether use of combined oral contraceptives containing third generation
progestogens is associated with altered risk of venous thromboembolism. Design: Matched …

Abstract In October 1995 the Committee on Safety of Medicines advised UK doctors and
pharmacists that oral contraceptives containing desogestrel and gestodene were associated …

Recent epidemiologic studies reported that the risk of venous thromboembolism (VTE) was
higher with the use of the newer third generation oral contraceptives than with second …

Objective To provide a comprehensive overview of the risk of venous thrombosis in women
using different combined oral contraceptives. Design Systematic review and network meta …